LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Rothman Clinic Sues Zurich Over COVID-19 Insurance Coverage
Legal & Regulatory and Reimbursement

Rothman Clinic Sues Zurich Over COVID-19 Insurance Coverage

September 22, 2021 2 min read Premium comments

Advertisement

Secondary#reconstructiveorthopaedicassociates#covid19#Rothmaninstitute#zurichamerican

Reconstructive Orthopaedic Associates II, LLC doing business as The Rothman Institute (Rothman) is suing Schaumburg, Illinois-based Zurich American Insurance Company (Zurich) over alleged damages related to the COVID-19 pandemic.

Last month, Rothman filed its lawsuit in the Court of Common Pleas of Philadelphia County, Pennsylvania. This month, Zurich removed the matter to the United States District Court for the Eastern District of Pennsylvania.

Rothman, with offices in Pennsylvania, New Jersey, and New York, is alleging in its complaint that Zurich issued a commercial property insurance policy to Rothman insuring Rothman’s various offices. Rothman claims that the company sustained “loss or damages covered under the insurance policy” and “Zurich has only agreed to cover a nominal portion of the loss or damages that Rothman has sustained due to the COVID-19 pandemic.”

The dispute arises over whether Rothman is entitled to insurance coverage for losses sustained during the statewide stay-at-home orders during the COVID-19 pandemic. Notably, Rothman argues that COVID-19 is a microorganism. Thus, under its policy with Zurich, it is entitled to coverage for loss or damages related to COVID-19.

Rothman also claims that during a June 12, 2020 phone call between Rothman and Zurich, Zurich agreed that Rothman business segments could “recover its business income losses if those business segments could not operate.” However, Rothman contends that on June 25, 2020, Zurich issued a letter stating that coverage was limited to that potentially available under “Communicable Disease Suspension of Operations – Business Income.”

Additionally, Rothman claims that Zurich limited coverage to four of Rothman’s administrative locations. Zurich purportedly denied coverage for Rothman’s healthcare locations because, as required under the policy, access was not prohibited, and the government never provided Rothman with a “notice of closing” for those locations. Rothman contends that it is entitled to coverage because patients were unable to enter a large number of its locations “due to government orders, CDC guidelines and directives and/or local healthcare related government restrictions.”

Per its complaint, Rothman is requesting the following: a declaration that there is coverage under its insurance policy; monetary damages in excess of $75,000.00; pre-judgment interest; and additional relief.

As of the date of this article, Zurich has not yet filed a response.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy